pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$AMRXAmneal Pharmaceuticals, Inc.

$AMRX20.30+1.15%
Bridgewater, NJ, USupdated 1d ago

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.

Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes

🐶 often sniffed alongside

top 8
  • tagRecall10 co-mentions · 9 sources
  • tagSmall Molecule7 co-mentions · 6 sources
  • drugCHLORPROMAZINE HYDROCHLORIDE4 co-mentions · 4 sources
  • drugtrimethoprim3 co-mentions · 2 sources
  • drugMAGNESIUM SULFATE2 co-mentions · 1 sources
  • drugmagnesium sulfate Pfizer2 co-mentions · 1 sources
  • drugmagnesium sulfate Fresenius2 co-mentions · 1 sources
  • drugmagnesium2 co-mentions · 1 sources
pipeline
36
marketed
29
phase 3
1
catalysts ytd
40
approvals ytd
28
recalls ytd
5

Pipeline(36)

view full pipeline →
pipeline depth36 products
Preclinical: 1Phase 2: 2Phase 3: 1Marketed: 29Unknown: 3
1Preclinical2Phase 21Phase 329Marketed3Unknown
Marketed
BREXPIPRAZOLE
5-hydroxytryptamine receptor 2A5-hydroxytryptamine receptor 1A
Marketed
Boruzu
Mantle Cell Lymphoma
Marketed
CALCIUM CHLORIDE 10%
cardiac arrest
Marketed
CUPRIC CHLORIDE
Marketed
Crexont
Parkinson's Disease
Marketed
DEFLAZACORT
Glucocorticoid receptor
Marketed
DOXYCYCLINE HYCLATE
Bacterial 70S ribosomeInterstitial collagenase
Marketed
ELTROMBOPAG OLAMINE
Thrombopoietin receptor
Marketed
EPIRUBICIN HYDROCHLORIDE
Breast Cancer
Marketed
Fenoglide
Hypercholesterolemia
Marketed
IOHEXOL
Marketed
LABETALOL HYDROCHLORIDE
Adrenergic receptor

📅 Upcoming

Oct 29, 2026
earnings
$AMRX20.30+1.15%
in 25d
Amneal Pharmaceuticals, Inc. earnings
Amneal Pharmaceuticals, Inc.
→

🕒 Recent(90d)

earnings (2)
Aug 4, 2026
earnings
$AMRX20.30+1.15%
2mo ago
Amneal Pharmaceuticals, Inc. earnings
Amneal Pharmaceuticals, Inc.
→
Jul 30, 2026
earnings
$AMRX20.30+1.15%
2mo ago
Amneal Pharmaceuticals, Inc. earnings
Amneal Pharmaceuticals, Inc.
→
view all catalysts →

Active trials

  • phase1SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of AMN1126 in Healthy Post-Menopausal Femalescompletedn=18
  • phase1A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyesrecruitingn=240
🐶 Hiring Signal
next earnings Oct 29, 2026
No open roles indexed yet — view Amneal Pharmaceuticals, Inc. jobs →

News

no news has mentioned this company yet
identifiers
ticker
$AMRX
SEC CIK
0001723128
country
US
source
sec_tickers
top tags
Cardiology4Hypertension3Infectious Disease3Major Depression3Oncology3
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 2m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?